1. The burden of health care-associated infection worldwide;WHO,2016
2. Antimicrobial resistance surveillance in Europe 2016. European Centre for Disease Prevention and Control. Available from: https://ecdc.europa.eu/en/publications-data/antimicrobial-resistance-surveillance-europe-2016 [accessed 06.08.19].
3. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. The Review on Antimicrobial Resistance; mayo 2016. Available from: https://amr-review.org/sites/default/files/160518_Final paper_with cover.pdf [accessed 06.08.19].
4. Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy;Escolà-Vergé;Infect Drug Resist,2019
5. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections;Horcajada;Clin Microbiol Rev,2019